ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736104 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736104; 2) Community: the network communities that were significantly associated with the response to NSC 736104; 3) Molecule: the relationships between components within communities and NSC 736104; 4) MDR: the compounds that were significantly associated with the NSC 736104.

NSC Compound Enrichment Correlation
NSC 674178 Null 0.000573863872925603 0.13856747
NSC 698954 Null 0.000573863872925603 0.078794577
NSC 704113 Null 0.000573863872925603 0.047500398
NSC 720702 Null 0.000573863872925603 -0.081143872
NSC 664343 Null 0.000602374785885765 0.20871765
NSC 720641 8-chloro-3-(3,5-dimethoxyphenylamino)-7-methyl-1,2,4-triazol o[4,3-b][1,2,4]benzodithiazine-5,5-dioxide 0.000602374785885765 0.071956151
NSC 744989 7-methoxy-8-[(5-2-methoxy-4-[(E)-3-(2,4-dimethyl-3-quinolyl)-3-oxo-1-propenyl]phenoxybutyl)oxy]-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.000610795106687072 0.09466633
NSC 762008 Copper(II) complex with a thiosemicarbazone as a ligand 0.000610795106687072 0.18461951
NSC 105132 Deoxycamptothecin 0.000610795106687085 -0.13541841
NSC 618770 Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide 0.000610795106687085 0.17978164
Total:141  Current:5    [First] [Prev] [Next] [Last]